191 related articles for article (PubMed ID: 9218821)
1. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy.
Rutjes SA; Vree Egberts WT; Jongen P; Van Den Hoogen F; Pruijn GJ; Van Venrooij WJ
Clin Exp Immunol; 1997 Jul; 109(1):32-40. PubMed ID: 9218821
[TBL] [Abstract][Full Text] [Related]
2. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.
Frank MB; McCubbin V; Trieu E; Wu Y; Isenberg DA; Targoff IN
J Autoimmun; 1999 Mar; 12(2):137-42. PubMed ID: 10047434
[TBL] [Abstract][Full Text] [Related]
3. Accessibility of epitopes on the 52-kD Ro/SSA protein (Ro52) and on the RoRNP associated Ro52 protein as determined by anti-peptide antibodies.
Ricchiuti V; Pruijn GJ; Thijssen JP; van Venrooij WJ; Muller S
J Autoimmun; 1997 Apr; 10(2):181-91. PubMed ID: 9185880
[TBL] [Abstract][Full Text] [Related]
4. Epitope specificity determines the ability of anti-Ro52 autoantibodies to precipitate Ro ribonucleoprotein particles.
Peek R; Pruijn GJ; van Venrooij WJ
J Immunol; 1994 Nov; 153(9):4321-9. PubMed ID: 7523522
[TBL] [Abstract][Full Text] [Related]
5. Latest update on the Ro/SS-A autoantibody system.
Schulte-Pelkum J; Fritzler M; Mahler M
Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
[TBL] [Abstract][Full Text] [Related]
7. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.
Bozic B; Pruijn GJ; Rozman B; van Venrooij WJ
Clin Exp Immunol; 1993 Nov; 94(2):227-35. PubMed ID: 7693382
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody profiles in the sera of European patients with myositis.
Brouwer R; Hengstman GJ; Vree Egberts W; Ehrfeld H; Bozic B; Ghirardello A; Grøndal G; Hietarinta M; Isenberg D; Kalden JR; Lundberg I; Moutsopoulos H; Roux-Lombard P; Vencovsky J; Wikman A; Seelig HP; van Engelen BG; van Venrooij WJ
Ann Rheum Dis; 2001 Feb; 60(2):116-23. PubMed ID: 11156543
[TBL] [Abstract][Full Text] [Related]
9. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
[TBL] [Abstract][Full Text] [Related]
11. Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity.
Kinoshita G; Keech CL; Sontheimer RD; Purcell A; McCluskey J; Gordon TP
Lupus; 1998; 7(1):7-11. PubMed ID: 9493142
[TBL] [Abstract][Full Text] [Related]
12. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
Ricchiuti V; Isenberg D; Muller S
J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
[TBL] [Abstract][Full Text] [Related]
13. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block.
Eftekhari P; Sallé L; Lezoualc'h F; Mialet J; Gastineau M; Briand JP; Isenberg DA; Fournié GJ; Argibay J; Fischmeister R; Muller S; Hoebeke J
Eur J Immunol; 2000 Oct; 30(10):2782-90. PubMed ID: 11069058
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
Koenig M; Fritzler MJ; Targoff IN; Troyanov Y; Senécal JL
Arthritis Res Ther; 2007; 9(4):R78. PubMed ID: 17688695
[TBL] [Abstract][Full Text] [Related]
15. Human autoantibodies directed against the RNA recognition motif of La (SS-B) bind to a conformational epitope present on the intact La (SS-B)/Ro (SS-A) ribonucleoprotein particle.
Rischmueller M; McNeilage LJ; McCluskey J; Gordon T
Clin Exp Immunol; 1995 Jul; 101(1):39-44. PubMed ID: 7542577
[TBL] [Abstract][Full Text] [Related]
16. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies.
Eloranta ML; Barbasso Helmers S; Ulfgren AK; Rönnblom L; Alm GV; Lundberg IE
Arthritis Rheum; 2007 Sep; 56(9):3112-24. PubMed ID: 17763410
[TBL] [Abstract][Full Text] [Related]
17. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
[TBL] [Abstract][Full Text] [Related]
18. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies.
Staikou EV; Routsias JG; Makri AA; Terzoglou A; Sakarellos-Daitsiotis M; Sakarellos C; Panayotou G; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2003 Oct; 134(1):143-50. PubMed ID: 12974767
[TBL] [Abstract][Full Text] [Related]
20. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity.
Keech CL; Gordon TP; McCluskey J
J Immunol; 1996 Oct; 157(8):3694-9. PubMed ID: 8871672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
